Literature DB >> 21079999

Overexpression of constitutively active BMP-receptor-IB in mouse skin causes an ichthyosis-vulgaris-like disease.

Xueyan Yu1, Ramón A Espinoza-Lewis, Cheng Sun, Lisong Lin, Fenglei He, Wei Xiong, Jing Yang, Alun Wang, Yiping Chen.   

Abstract

The skin is the outer layer of protection against the environment. The development and formation of the skin is regulated by several genetic cascades including the bone morphogenetic protein (BMP) signaling pathway, which has been suggested to play an important role during embryonic organ development. Several skin defects and diseases are caused by genetic mutations or disorders. Ichthyosis is a common genetic skin disorder characterized by dry scaly skin. Loss-of-function mutations in the filaggrin (FLG) gene have been identified as the cause of the ichthyosis vulgaris (IV) phenotype; however, the direct regulation of filaggrin expression in vivo is unknown. We present evidence that BMP signaling regulates filaggrin expression in the epidermis. Mice expressing a constitutively active form of BMP-receptor-IB in the developing epidermis exhibit a phenotype resembling IV in humans, including dry flaky skin, compact hyperkeratosis, and an attenuated granular layer associated with a significantly downregulated expression of filaggrin. Regulation of filaggrin expression by BMP signaling has been further confirmed by the application of exogenous BMP2 in skin explants and by a transgenic model overexpressing Noggin in the epidermis. Our results demonstrate that aberrant BMP signaling in the epidermis causes overproliferation and hyperkeratinization, leading to an IV-like skin disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079999      PMCID: PMC3016643          DOI: 10.1007/s00441-010-1077-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  43 in total

1.  Clinical features of autosomal dominant and sex-linked ichthyosis in an English population.

Authors:  R S Wells; C B Kerr
Journal:  Br Med J       Date:  1966-04-16

2.  Novel and recurring ABCA12 mutations associated with harlequin ichthyosis: implications for prenatal diagnosis.

Authors:  A C Thomas; C Sinclair; N Mahmud; T Cullup; J E Mellerio; J Harper; B A Dale; C Turc-Carel; D Hohl; J A McGrath; A Vahlquist; M Hellstrom-Pigg; A Ganemo; K Metcalfe; C A Mein; E A O'Toole; D P Kelsell
Journal:  Br J Dermatol       Date:  2007-11-06       Impact factor: 9.302

Review 3.  Recent advances in BMP receptor signaling.

Authors:  Christina Sieber; Jessica Kopf; Christian Hiepen; Petra Knaus
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-07       Impact factor: 7.638

4.  Complex interactions between epidermal POU domain and activator protein 1 transcription factors regulate the expression of the profilaggrin gene in normal human epidermal keratinocytes.

Authors:  S I Jang; N Karaman-Jurukovska; M I Morasso; P M Steinert; N G Markova
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Noggin is a mesenchymally derived stimulator of hair-follicle induction.

Authors:  V A Botchkarev; N V Botchkareva; W Roth; M Nakamura; L H Chen; W Herzog; G Lindner; J A McMahon; C Peters; R Lauster; A P McMahon; R Paus
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

6.  Targeted misexpression of constitutively active BMP receptor-IB causes bifurcation, duplication, and posterior transformation of digit in mouse limb.

Authors:  Z Zhang; X Yu; Y Zhang; B Geronimo; A Lovlie; S H Fromm; Y Chen
Journal:  Dev Biol       Date:  2000-04-15       Impact factor: 3.582

7.  ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters.

Authors:  Ying Zuo; Debbie Z Zhuang; Rong Han; Giorgis Isaac; Jennifer J Tobin; Mary McKee; Ruth Welti; Janice L Brissette; Michael L Fitzgerald; Mason W Freeman
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Hand2 is required in the epithelium for palatogenesis in mice.

Authors:  Wei Xiong; Fenglei He; Yuka Morikawa; Xueyan Yu; Zunyi Zhang; Yu Lan; Rulang Jiang; Peter Cserjesi; Yiping Chen
Journal:  Dev Biol       Date:  2009-03-31       Impact factor: 3.582

9.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

10.  A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis.

Authors:  Ian Smyth; Douglas F Hacking; Adrienne A Hilton; Nigora Mukhamedova; Peter J Meikle; Sarah Ellis; Keith Satterley; Keith Slattery; Janelle E Collinge; Carolyn A de Graaf; Melanie Bahlo; Dmitri Sviridov; Benjamin T Kile; Douglas J Hilton
Journal:  PLoS Genet       Date:  2008-09-19       Impact factor: 5.917

View more
  4 in total

1.  AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation.

Authors:  A S Naeem; Y Zhu; W L Di; S Marmiroli; R F L O'Shaughnessy
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

2.  Enhanced BMP signaling prevents degeneration and leads to endochondral ossification of Meckel's cartilage in mice.

Authors:  Ying Wang; Yuqian Zheng; Di Chen; YiPing Chen
Journal:  Dev Biol       Date:  2013-07-23       Impact factor: 3.582

3.  Bone morphogenetic protein signaling suppresses wound-induced skin repair by inhibiting keratinocyte proliferation and migration.

Authors:  Christopher J Lewis; Andrei N Mardaryev; Krzysztof Poterlowicz; Tatyana Y Sharova; Ahmar Aziz; David T Sharpe; Natalia V Botchkareva; Andrey A Sharov
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

4.  Differential gene expression in skin RNA of horses affected with degenerative suspensory ligament desmitis.

Authors:  Abigail Haythorn; Madeline Young; James Stanton; Jian Zhang; P O E Mueller; Jaroslava Halper
Journal:  J Orthop Surg Res       Date:  2020-10-07       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.